MetaCap

Medline (MDLN) vs Solventum (SOLV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Medline is the larger company by market cap ($48.75 billion vs $14.36 billion), about 3.4 times the size. On valuation, Solventum trades at a lower forward P/E (11.2x vs 24.0x for Medline). Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 4.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MDLN-9.66%SOLV+5.69%
+24%-0%-25%
Dec 17, 20251 yearNov 20, 2026
MDLN-11.07%SOLV+3.57%
+22%-2%-26%
Dec 15, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MDLN versus SOLV key metrics
MetricMDLNSOLV
Share price$37.04$84.50
Market cap$48.75B$14.36B
1-day change-2.11%-1.52%
YTD return-11.81%+6.64%
1-year return—+1.93%
P/E ratio (TTM)84.1894.94
Forward P/E23.9811.20
EPS (TTM)$0.44$0.89
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$28.43B$8.32B
Revenue growth (YoY)—+0.86%
Net income (latest FY)$1.16B$1.56B
Gross margin26.44%53.47%
Operating margin7.78%26.20%
Net margin4.08%18.69%
52-week high$50.88$94.16
52-week low$31.37$62.38
Distance from 52-week high-27.20%-10.26%
Analyst consensusbuybuy
Avg. price target upside+23.52%+16.43%
Average volume9.55M1.03M
Shares outstanding878.66M169.96M
Employees45,00020,584
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Medline is about 3.4 times larger than Solventum by market value ($48.75B vs $14.36B).
  • Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus 4.1 cents for Medline.

About Medline

MDLN stock →

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.

Health Care · Medical/Dental Instruments · 45,000 employees

About Solventum

SOLV stock →

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.

Health Care · Medical/Dental Instruments · 20,584 employees

MDLN vs SOLV FAQ

Which is bigger, Medline or Solventum?

Medline (MDLN) is larger, with a market capitalization of $48.75B compared with $14.36B for Solventum (SOLV).

Which has the lower P/E ratio, MDLN or SOLV?

MDLN has the lower trailing P/E at 84.2, versus 94.9 for SOLV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Medline and Solventum in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons